This message contains images. If you don't see images, click here to view.
Advertise in this news brief.



Text version   RSS   Subscribe   Unsubscribe   Archive   Media Kit December 11, 2014
Advertisement
   NAMCP Medical Directors Institute   AAMCN    AAIHDS    Conferences    JMCM    Contact Us  

Fall Managed Care Forum
Nov. 13-14, 2014
Bellagio Hotel
Las Vegas Nevada


Click here to visit the conference website.

Click Here to view our Complimentary Online CME/CEU Webcasts

Otezla® (apremilast) is approved for the treatment of patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. Please click here for more information.

 



2014 Innovation Award Winners
NAMCP, AAMCN and AAIHDS are pleased to announce the winners of the first annual Innovation Awards, which recognize a company or organization that is improving outcomes, costs or quality using an innovative method in the workplace. The award winners are as follows:

NAMCP Medical Directors Institute Innovation Award Winner: Yale-New Haven

AAMCN Innovation Award Winner: MDWise

AAIHDS Innovation Award Winner: Keystone First, an affiliate of AmeriHealth Caritas
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article




Save the date: 2015 Spring Managed Care Forum

Save the date for the 2015 Spring Forum being held April 23-24, 2015 at Disney's Yacht & Beach Club. More information will be available shortly.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


GENOMICS


How well you sleep may depend on your genes
HealthDay News via CBS News
How much sleep you get each night may depend to some extent on your genes, a new study suggests. "Sleep patterns are influenced by genetic differences," said study co-author Dr. Daniel Gottlieb, a sleep researcher and associate professor of medicine at Harvard Medical School.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SPONSORED CONTENT


Genes may play greater role in Lou Gehrig's disease
The Huffington Post
In most cases of Lou Gehrig's disease, or amyotrophic lateral sclerosis, it's not known what caused the condition, but a new study finds genes may play a larger role than previously thought. Only about 5 to 10 percent of people with ALS have family members with the disease, meaning the cases have a known genetic component.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Sifting through genes in search of answers on Ebola
The New York Times
An old two-story brick building in a shabby part of town, formerly a distribution center for Budweiser beer, is now the world’s most powerful factory for analyzing genes from people and viruses. And it is a factory.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Measure, Monitor Immunoglobulin Treatment Outcomes
BioFeedback for immunoglobulin is a health outcomes reporting program that provides clinical feedback on the use of immunoglobulin in autoimmune-related disorders. Physicians and medical directors can now deploy clinical interventions when they have the greatest impact on healthcare quality and costs.

Request more information or schedule a personal introduction.
 


Genes that cause pancreatic cancer identified by new tool
Medical Xpress
A technique that can identify causes of cancer invisible to genetic sequencing has uncovered large sets of previously unknown pancreatic cancer genes. It is hoped that this study will boost research into a disease that is still poorly understood and for which five-year survival rates have stood at around 5 per cent for the past four decades.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


BIOTECH/DIAGNOSTICS/PERSONALIZED MEDICINE


Genomics: What you should know
Forbes
Personalized medicine. Predictive medicine. Targeted medicine. These are just some of the descriptors being applied to “genomic medicine,” a field of medical research generating much fanfare and hope for the future. Genomics, according to the Centers for Disease Control and Prevention, is the study of all the genes in the human genome — that double-stranded DNA helix that defines who we are and what we’re made of.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  FEATURED COMPANIES
What is Solesta?

What does a good day mean for your patients?

LEARN MORE
Advertise here!

To find out how to feature your company in the GBEMTI eNewsletter and other advertising opportunities, Contact Geoffrey Forneret at 469-420-2629.
MORE


23andMe and the future of home DNA testing
Medical News Today
Recently, it was announced that the Google-associated home DNA screening kit, 23andMe will be launched in the U.K. In the US, however, 23andMe remains banned — a Food and Drug Administration order issued in November 2013 instructed the company to desist from marketing their eponymous genomics kit in the U.S.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


REGENERATIVE MEDICINE


New single-cell analysis reveals complex variations in stem cells
Phys.org
Stem cells offer great potential in biomedical engineering due to their pluripotency, which is the ability to multiply indefinitely and also to differentiate and develop into any kind of the hundreds of different cells and bodily tissues. But the precise complexity of how stem cell development is regulated throughout states of cellular change has been difficult to pinpoint until now.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  InSightec - World Leader in MRgFUS

MRgFUS is being used in clinics across America to treat uterine fibroids and pain palliation for metastatic bone tumors. It’s a completely non-invasive procedure performed on an outpatient basis where patients report an improvement in QoL within days, not weeks. Discover InSightec now.
 


Blood grown from stem cells could transform transfusions
The Guardian
In 2007, a team of researchers from the U.K. and Irish Blood services responded to an oddly specific call from the U.S. military. They wanted scientists to help them build a machine, no bigger than two and a half washing machines, that could be dropped from a helicopter on to a battle field and generate stem-cell-derived blood for injured soldiers.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


The NFL has a problem with stem cell treatments
MIT Technology Review
Elite athletes do whatever it takes to win. Lately, that’s meant getting an injection of their own stem cells. The treatments, developed over the last eight years, typically involve extracting a small amount of a player’s fat or bone marrow and then injecting it into an injured joint or a strained tendon to encourage tissue regeneration.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Advancement revolutionizes hereditary cancer testing

Myriad myRisk™ Hereditary Cancer utilizes both genetic test status AND personal cancer family history to identify elevated risk for 8 important cancers by analyzing multiple, clinically significant genes. Myriad myRisk improves clinical sensitivity by 40-50% compared to current testing paradigms in a cost-effective manner, providing more value to your members.
 


EMERGING MEDICAL TECHNOLOGIES


4 interesting tech trends in patient monitoring
Forbes
As important as the relationships between patients and healthcare professionals are, a doctor or nurse can’t be in the room with each patient at all times, even in a fully-staffed hospital. As such, a variety of electronic monitoring equipment is generally available to monitor such metrics as the electrical activity of the heart, respiration rate, blood pressure, body temperature, cardiac output and the amount of oxygen and carbon dioxide in the blood.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


50K lives saved by better technology
Health IT Outcomes
Hospitals are adopting more and more technology and, as a result, seeing a reduction in the number of hospital acquired conditions and medical errors that lead to preventable deaths. According to an Agency for Healthcare Research and Quality report, U.S. hospitals have seen a 17 percent decline in preventable mortalities since 2012, meaning more than 50,000 lives have been saved.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA: NEW TREATMENTS AND TECHNOLOGY


For treatment of polycythemia vera, FDA approves Jakafi, a targeted therapy
Forbes
The FDA approved Jakafi, a pill, for use in treating polycythemia vera. The drug, a targeted kinase inhibitor manufactured by Incyte, offers a needed option for some people affected by this serious blood disorder, a type of myeloproliferative disease.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Miss an issue of Genomics Biotech and Emerging Medical Technologies Institute eBrief? Click here to visit the archive page.


Amgen says FDA approves Xgeva as a treatment for rare bone-destroying cancer complication
The Associated Press via Fox News
Amgen's Xgeva, which is used to treat bone disorders related to cancer, received an additional U.S. marketing approval. The Food and Drug Administration approved Xgeva as a treatment for hypercalcemia of malignancy, a condition in which a patient's bones break down at an accelerated rate, the company said.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


ACCOUNTABLE CARE ORGANIZATIONS


Riskless ACOs may invite abuse
Modern Healthcare
The hope that accountable care would rapidly diffuse across the healthcare landscape to help reduce costs suffered another setback when federal officials last week admitted few Medicare ACOs are ready to assume financial risk. To keep existing ACOs from dropping out, the CMS proposed an expanded menu of incentives to keep hospitals and doctors involved while postponing when providers would actually face potential losses for three more years.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


5 key changes providers can expect from the new ACO rule proposal
Healthcare Dive
When CMS unveiled its accountable care organization program in 2011, it was met with trepidation from some healthcare providers, many of whom were uncomfortable with the parameters of risk and reward outlined in the program.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


MANAGED HEALTHCARE NEWS


In healthcare, managing access rights is a necessary mandate
By Dean Wiech
Access to critical data is paramount criteria for business success. Physicians and nurses need access to patients' records to insure proper delivery of care, and encumbering employees and internal stakeholders by placing too many restrictions or complicated access methodologies upon internal systems can have catastrophic consequences. However, too little control or restrictions to information in internal systems can lead to violations for healthcare organizations.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Why millennials hate their least expensive healthcare option
TIME
Health plans that shift more up-front costs onto you are rapidly becoming the norm. But millennials don't seem happy about taking on the risk, even in exchange for a lower price. Millennials want their parents' old health insurance plan. A new survey from Bankrate found that almost half of 18-to-29-year-olds prefer a health plan with a lower deductible and higher premiums — meaning millennials would rather pay more out of their paycheck every month and pay less when they go to the doctor.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FAST FACTS
"The largest waterborne disease outbreak in United States history occurred in 1993 in Milwaukee when over 400,000 people became ill with diarrhea when the parasite Cryptosporidium was found in the city's drinking water supply."


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Could the key to a good memory be found in our genes? (Medical News Today)
New data settles the debate: Obamacare is making health insurance more affordable, not less (The Huffington Post)
Top 10 technology hazards for 2015 (Health Data Mangement)
Podcast: How the Pioneer ACO fallout affects the future of risk-based, population health (Healthcare Informatics)
Who are the stars of personalized meds? Roche, Novartis and J&J (FiercePharma)

Don't be left behind. Click here to see what else you missed.
 

Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2635
Download media kit

Natalie Rodriguez, Senior Content Editor, 469.420.2635   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Dec. 4, 2014
Nov. 27, 2014
Nov. 20, 2014
Nov. 13, 2014



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063